CHRS vs MSFT · rev $26.6M vs P/E 39, rev $331.84B
Coherus BioSciences Inc (CHRS) versus Microsoft Corporation (MSFT) — a side-by-side from cached financials, not a winner call.
Coherus BioSciences Inc (CHRS) is a biotechnology company listed on US.
Microsoft Corporation (MSFT) is a software - infrastructure company listed on US. It is led by Satya Nadella.
Latest reported CHRS revenue for 2026-06-30 was $26.6M. Net income was -$59.0M. CHRS currently screens at market cap $223.7M.
Latest reported MSFT revenue for 2026-06-30 was $331.84B. Net income was $133.75B. MSFT currently screens at market cap $3.71T and trailing P/E 38.6.
CHRS currently screens at market cap $223.7M. MSFT currently screens at market cap $3.71T and trailing P/E 38.6.
Not investment advice. Open the CHRS and MSFT stock pages for the full models.
Not investment advice.